12 insiders reported 174 Form 4 transactions for KalVista Pharmaceuticals, Inc. (KALV) over the past 18 months (most recent 2026-06-11). Recent activity: Palleiko Benjamin L (CHIEF EXECUTIVE OFFICER) Sell 479,989 shares, Yea Christopher (CHIEF DEVELOPMENT OFFICER) Sell 229,918 shares, Piekos Brian (Chief Financial Officer) Sell 21,661 shares, Sweeny Nicole (Chief Commercial Officer) Sell 59,291 shares, Audhya Paul K. (CHIEF MEDICAL OFFICER) Sell 150,260 shares. Source: SEC Form 4.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-06-11 | Palleiko Benjamin L | CHIEF EXECUTIVE OFFICER | Sell | 479,989 | $0 |
| 2026-06-11 | Yea Christopher | CHIEF DEVELOPMENT OFFICER | Sell | 229,918 | $0 |
| 2026-06-11 | Piekos Brian | Chief Financial Officer | Sell | 21,661 | $0 |
| 2026-06-11 | Sweeny Nicole | Chief Commercial Officer | Sell | 59,291 | $0 |
| 2026-06-11 | Audhya Paul K. | CHIEF MEDICAL OFFICER | Sell | 150,260 | $0 |
| 2026-05-29 | Yea Christopher | CHIEF DEVELOPMENT OFFICER | Buy | 33,800 | $238,966 |
| 2026-05-29 | Yea Christopher | CHIEF DEVELOPMENT OFFICER | Sell | 33,800 | $905,225 |
| 2026-05-27 | Yea Christopher | CHIEF DEVELOPMENT OFFICER | Buy | 3,125 | $0 |
| 2026-05-27 | Audhya Paul K. | CHIEF MEDICAL OFFICER | Buy | 5,000 | $0 |
| 2026-05-27 | Sweeny Nicole | Chief Commercial Officer | Buy | 5,000 | $0 |
| 2026-05-27 | Audhya Paul K. | CHIEF MEDICAL OFFICER | Sell | 2,239 | $59,955 |
| 2026-05-27 | Sweeny Nicole | Chief Commercial Officer | Sell | 1,489 | $39,872 |
| 2026-05-27 | Yea Christopher | CHIEF DEVELOPMENT OFFICER | Sell | 1,966 | $52,645 |
| 2026-05-26 | Sweeny Nicole | Chief Commercial Officer | Buy | 6,250 | $0 |
| 2026-05-26 | Yea Christopher | CHIEF DEVELOPMENT OFFICER | Buy | 3,750 | $0 |
| 2026-05-26 | Piekos Brian | Chief Financial Officer | Buy | 5,000 | $0 |
| 2026-05-26 | Audhya Paul K. | CHIEF MEDICAL OFFICER | Buy | 6,250 | $0 |
| 2026-05-26 | Palleiko Benjamin L | CHIEF EXECUTIVE OFFICER | Buy | 23,250 | $0 |
| 2026-05-26 | Palleiko Benjamin L | CHIEF EXECUTIVE OFFICER | Sell | 10,926 | $292,646 |
| 2026-05-26 | Yea Christopher | CHIEF DEVELOPMENT OFFICER | Sell | 2,358 | $63,158 |
| 2026-05-26 | Piekos Brian | Chief Financial Officer | Sell | 1,489 | $39,882 |
| 2026-05-26 | Sweeny Nicole | Chief Commercial Officer | Sell | 1,861 | $49,846 |
| 2026-05-26 | Audhya Paul K. | CHIEF MEDICAL OFFICER | Sell | 2,685 | $71,916 |
| 2026-05-19 | Yea Christopher | CHIEF DEVELOPMENT OFFICER | Buy | 1,774 | $0 |
| 2026-05-19 | Audhya Paul K. | CHIEF MEDICAL OFFICER | Buy | 2,419 | $0 |
Source: SEC Form 4 filings · as of 2026-06-11